Perspectives

Decision Latency Is a Growth Strategy Problem: Redesigning Portfolio Governance for Speed and Discipline

Intended Reader Heads of Portfolio and Pipeline Strategy who own the evaluation and key decisions involved in portfolio …

AI Is Not Ready to Be the Decision-Maker, And Pretending Otherwise Is the Real Risk

The industry's AI rhetoric has outrun its AI maturity by several years, and the gap is being covered up with confidence …

Stop Asking Build vs. Buy: Most Biotechs Don't Have an AI Strategy at All

Intended Reader Biotech leadership teams, strategic advisors, and board members debating enterprise AI deployment. Key …

The Portfolio Imperative: Converting AI Investment into Compounding Enterprise Value

| Intended Reader For biopharma CEOs, Chief Digital Officers, Chief Operating Officers, and other C-suite executives …

From Dealmaking to Strategic Access: The New Partnership Agenda in Life Sciences

Strategic Ambition is Not Enough: The Value Realization Imperative for Biopharma

| Intended Reader C-suite and Board-level executives: Leaders questioning whether their organization's strategic …

The Use of Decentralized Clinical Trials (DCTs)

Strategic Growth, Patient Benefits, and Practical Challenges | Intended Reader For biopharma leaders, clinical …

Challenging Times Require a Disciplined Approach to Process Improvement

| Intended Reader Operational and strategic leaders in life sciences Improvement initiative leaders Functional process …

The Calendar is the Real Operating System of Leadership (And It's Failing Us)

| Intended Reader For senior leaders and leadership teams who want to turn time from a liability into their most …

Escape Meeting Purgatory with Strategic Business Management

Transform your leadership team's operating rhythm and drive real results | Intended Reader If you're on a leadership …

Harnessing Structure for Leadership Excellence: A Business Manager's Blueprint

| Intended Reader Functional Leaders Business Managers | Key Takeaways Effective team management benefits from …

The Evolving World of Global Regulatory Affairs: Navigating Change and Embracing Innovation

| Intended Reader Biopharma leaders | Key Takeaways Project Orbis is a case study for cross-market regulatory …